Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Silence Therapeutics plc SLN

Set alert

Price alert · SLN

All alert types
19.76 USD +0.01 +0.05%

At close · Nov 2

19.76 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
19.76 × 2
Ask
19.77 × 2
19.75 Day range 19.80
4.19 52-week range 19.87
YTD
+225.00%
1 year
+175.98%
Open
19.75
Prev close
19.75
Mkt cap
1.23B
Vol
1.19M
Avg vol
2.77M
EPS
-1.29
P/E
0.00
Div yield
0.00%
More statistics
Low
19.75
High
19.80
Forward P/E
-52.00
Beta
1.34
Short ratio
2.70
Inst. own
47.74%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
13.48
200-d avg
9.06
1y target
19.75

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for SLN has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-2.57 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 5
  • P/E 1
  • P/B 2

Valuation

P/E -1.1×
FY 2016: -43.9×FY 2017: -208×FY 2018: -19.6×FY 2019: -18.9×FY 2020: -14.5×FY 2021: -13.1×FY 2022: -3.3×FY 2023: -3.9×FY 2024: -2.3×FY 2025: -1.1×
FY 2016 5y median -3.3× FY 2025
P/S 171×
FY 2016: 477×FY 2017: 21032×FY 2018: 0.0×FY 2019: 1509×FY 2020: 80.1×FY 2021: 42.2×FY 2022: 7.7×FY 2023: 6.7×FY 2024: 2.0×FY 2025: 171×
FY 2016 5y median 7.7× FY 2025
P/B 1.5×
FY 2016: 6.8×FY 2017: 6.4×FY 2018: 10.2×FY 2019: 17.6×FY 2020: 48.4×FY 2021: 61.4×FY 2022: 6.1×FY 2023: 7.7×FY 2024: 0.8×FY 2025: 1.5×
FY 2016 5y median 6.1× FY 2025
P/FCF -1.5×
FY 2016: -34.7×FY 2017: -34.4×FY 2018: -21.1×FY 2019: 214×FY 2020: -38.9×FY 2021: 70.9×FY 2022: -2.3×FY 2023: -4.3×FY 2024: -1.6×FY 2025: -1.5×
FY 2016 5y median -1.6× FY 2025
EV/EBITDA -1.0×
FY 2016: -28.3×FY 2017: -88.3×FY 2018: -16.7×FY 2019: -15.9×FY 2020: -11.6×FY 2021: -9.9×FY 2022: -2.0×FY 2023: -2.3×FY 2024: 0.2×FY 2025: -1.0×
FY 2016 5y median -2.0× FY 2025
EV/Sales 151×
FY 2016: 427×FY 2017: 18360×FY 2018: 0.0×FY 2019: 1455×FY 2020: 75.2×FY 2021: 36.2×FY 2022: 4.6×FY 2023: 4.5×FY 2024: -0.3×FY 2025: 151×
FY 2016 5y median 4.6× FY 2025
FCF Yield -65.1%
FY 2016: -2.9%FY 2017: -2.9%FY 2018: -4.7%FY 2019: 0.5%FY 2020: -2.6%FY 2021: 1.4%FY 2022: -42.6%FY 2023: -23.3%FY 2024: -64.0%FY 2025: -65.1%
FY 2016 5y median -42.6% FY 2025

Profitability

Gross Margin 61.5%
FY 2016: -1031.3%FY 2017: -49543.8%FY 2018: 0.0%FY 2019: 100.0%FY 2020: 31.3%FY 2021: 39.9%FY 2022: 37.8%FY 2023: 59.3%FY 2024: 72.7%FY 2025: 61.5%
FY 2016 5y median 59.3% FY 2025
Operating Margin -16056.0%
FY 2016: -1546.2%FY 2017: -89943.8%FY 2018: 0.0%FY 2019: -9317.2%FY 2020: -654.3%FY 2021: -369.0%FY 2022: -281.9%FY 2023: -195.5%FY 2024: -146.4%FY 2025: -16056.0%
FY 2016 5y median -281.9% FY 2025
Net Margin -15851.9%
FY 2016: -1096.1%FY 2017: -10112.5%FY 2018: 0.0%FY 2019: -8025.4%FY 2020: -594.0%FY 2021: -317.4%FY 2022: -232.4%FY 2023: -170.5%FY 2024: -104.7%FY 2025: -15851.9%
FY 2016 5y median -232.4% FY 2025
ROE -142.2%
FY 2016: -15.6%FY 2017: -3.1%FY 2018: -52.5%FY 2019: -93.7%FY 2020: -359.3%FY 2021: -462.2%FY 2022: -185.9%FY 2023: -196.7%FY 2024: -42.3%FY 2025: -142.2%
FY 2016 5y median -185.9% FY 2025
ROIC -76.1%
FY 2016: -17.9%FY 2017: -11.8%FY 2018: -52.6%FY 2019: -53.0%FY 2020: -53.3%FY 2021: -48.5%FY 2022: -57.9%FY 2023: -55.4%FY 2024: -42.6%FY 2025: -76.1%
FY 2016 5y median -55.4% FY 2025
ROA -67.4%
FY 2016: -15.1%FY 2017: -2.9%FY 2018: -47.3%FY 2019: -42.5%FY 2020: -37.9%FY 2021: -41.0%FY 2022: -38.2%FY 2023: -45.8%FY 2024: -28.0%FY 2025: -67.4%
FY 2016 5y median -41.0% FY 2025

Growth (YoY)

Revenue -98.7%
FY 2016: 0.0%FY 2017: -97.9%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 2145.5%FY 2021: 126.6%FY 2022: 42.2%FY 2023: 43.7%FY 2024: 70.5%FY 2025: -98.7%
FY 2016 FY 2025
Operating Income -41.7%
FY 2016: -21.9%FY 2017: -20.9%FY 2018: -42.9%FY 2019: -10.5%FY 2020: -57.7%FY 2021: -27.8%FY 2022: -8.6%FY 2023: 0.3%FY 2024: -27.6%FY 2025: -41.7%
FY 2016 FY 2025
EPS (diluted) -139.2%
FY 2016: -20.0%FY 2017: 80.8%FY 2018: -1025.5%FY 2019: 0.0%FY 2020: -42.3%FY 2021: -21.6%FY 2022: -180.0%FY 2023: 7.9%FY 2024: 31.9%FY 2025: -139.2%
FY 2016 FY 2025
Free Cash Flow -15.0%
FY 2016: -16.5%FY 2017: 7.8%FY 2018: -73.4%FY 2019: 110.1%FY 2020: -757.2%FY 2021: 165.4%FY 2022: -879.8%FY 2023: 31.6%FY 2024: -37.6%FY 2025: -15.0%
FY 2016 FY 2025

Financial Health

Current Ratio 8.7×
FY 2016: 26.1×FY 2017: 17.1×FY 2018: 7.7×FY 2019: 3.9×FY 2020: 3.0×FY 2021: 5.7×FY 2022: 4.4×FY 2023: 4.6×FY 2024: 11.1×FY 2025: 8.7×
FY 2016 5y median 5.7× FY 2025
Quick Ratio 8.7×
FY 2016: 26.1×FY 2017: 17.1×FY 2018: 7.7×FY 2019: 3.9×FY 2020: 3.0×FY 2021: 5.7×FY 2022: 4.4×FY 2023: 4.6×FY 2024: 11.1×FY 2025: 8.7×
FY 2016 5y median 5.7× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: 3.4×FY 2017: 12.8×FY 2018: 1.1×FY 2019: 0.6×FY 2020: 0.8×FY 2021: 1.6×FY 2022: 1.4×FY 2023: 1.1×FY 2024: 2.0×FY 2025: 0.1×
FY 2016 5y median 1.4× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: -959×FY 2018: 0.0×FY 2019: -689×FY 2020: -2240×FY 2021: -5727×FY 2022: -1059×FY 2023: -1459×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median -1059× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31